Pavlovian Conditioned Approach, conditioned reinforcement, number of lever reinforcers received during the 40 min session
Tags: Behavior · Pavlovian conditioned approach · Conditioned reinforcement
Project: p50_paul_meyer_2014
1 loci · 1 genes with independent associations · 3 total associated genes
# | Chr | Start pos | End pos | # assoc genes | # joint models | Best TWAS P | Best GWAS P | Cond GWAS P | Joint genes |
---|---|---|---|---|---|---|---|---|---|
1 | 1 | 154277716 | 156447903 | 3 | 1 | 2.19e-07 | 2.19e-07 | 1e+00 | P2ry2 |
Tissue | RNA modality | # hits | % hits/tests | Avg chisq |
---|---|---|---|---|
Adipose | alternative polyA | 2 | 0.1 | 1.4 |
Adipose | alternative TSS | 0 | 0 | 1.45 |
Adipose | gene expression | 0 | 0 | 1.42 |
Adipose | isoform ratio | 0 | 0 | 1.31 |
Adipose | intron excision ratio | 0 | 0 | 1.24 |
Adipose | mRNA stability | 1 | 0 | 1.44 |
BLA | alternative polyA | 0 | 0 | 1.3 |
BLA | alternative TSS | 0 | 0 | 1.65 |
BLA | gene expression | 0 | 0 | 1.5 |
BLA | isoform ratio | 0 | 0 | 1.34 |
BLA | intron excision ratio | 0 | 0 | 1.42 |
BLA | mRNA stability | 0 | 0 | 1.43 |
Brain | alternative polyA | 0 | 0 | 1.45 |
Brain | alternative TSS | 0 | 0 | 1.41 |
Brain | gene expression | 0 | 0 | 1.44 |
Brain | isoform ratio | 0 | 0 | 1.38 |
Brain | intron excision ratio | 0 | 0 | 1.39 |
Brain | mRNA stability | 0 | 0 | 1.46 |
Eye | alternative polyA | 0 | 0 | 1.32 |
Eye | alternative TSS | 0 | 0 | 1.33 |
Eye | gene expression | 0 | 0 | 1.5 |
Eye | isoform ratio | 0 | 0 | 1.75 |
Eye | intron excision ratio | 0 | 0 | 1.5 |
Eye | mRNA stability | 0 | 0 | 1.49 |
IL | alternative polyA | 0 | 0 | 1.21 |
IL | alternative TSS | 0 | 0 | 1.34 |
IL | gene expression | 0 | 0 | 1.4 |
IL | isoform ratio | 0 | 0 | 1.35 |
IL | intron excision ratio | 0 | 0 | 1.37 |
IL | mRNA stability | 0 | 0 | 1.36 |
LHb | alternative polyA | 0 | 0 | 1.28 |
LHb | alternative TSS | 0 | 0 | 1.24 |
LHb | gene expression | 0 | 0 | 1.41 |
LHb | isoform ratio | 0 | 0 | 1.34 |
LHb | intron excision ratio | 0 | 0 | 1.29 |
LHb | mRNA stability | 0 | 0 | 1.51 |
Liver | alternative polyA | 4 | 0.3 | 1.46 |
Liver | alternative TSS | 0 | 0 | 1.39 |
Liver | gene expression | 0 | 0 | 1.43 |
Liver | isoform ratio | 0 | 0 | 1.36 |
Liver | intron excision ratio | 0 | 0 | 1.38 |
Liver | mRNA stability | 0 | 0 | 1.46 |
NAcc | alternative polyA | 0 | 0 | 1.38 |
NAcc | alternative TSS | 0 | 0 | 1.35 |
NAcc | gene expression | 0 | 0 | 1.46 |
NAcc | isoform ratio | 0 | 0 | 1.37 |
NAcc | intron excision ratio | 0 | 0 | 1.32 |
NAcc | mRNA stability | 0 | 0 | 1.47 |
OFC | alternative polyA | 0 | 0 | 1.18 |
OFC | alternative TSS | 0 | 0 | 1.47 |
OFC | gene expression | 0 | 0 | 1.45 |
OFC | isoform ratio | 0 | 0 | 1.32 |
OFC | intron excision ratio | 0 | 0 | 1.28 |
OFC | mRNA stability | 0 | 0 | 1.47 |
PL | alternative polyA | 0 | 0 | 1.28 |
PL | alternative TSS | 0 | 0 | 1.56 |
PL | gene expression | 0 | 0 | 1.44 |
PL | isoform ratio | 0 | 0 | 1.36 |
PL | intron excision ratio | 0 | 0 | 1.39 |
PL | mRNA stability | 0 | 0 | 1.46 |